
Statistics show that women and underrepresented groups tend to apply to jobs only if they meet 100% of the qualifications. Sobi encourages you to change that statistic and apply. Rarely do candidates meet 100% of the qualifications. We look forward to your application!
At Sobi, each person brings their unique talents to work as a team and make a difference. We are dedicated to developing and delivering innovative therapies to improve the lives of people who live with a rare disease. Our edge comes from our team of people and our commitment to patients.
Are you ready to make a real difference in patients’ lives? At Sobi, we’re on a mission to transform the rare disease space, and we’re looking for a passionate, driven Key Account Manager to join us as we launch groundbreaking new products in Australia.
This is your opportunity to be part of something extraordinary. You’ll work at the forefront of rare disease treatment, building strong partnerships with healthcare professionals (HCPs), driving patient identification, and enabling access to life-changing therapies. Every day, your work will help address unmet medical needs and improve patient outcomes.
What You’ll Do
What We’re Looking For
Why Join Sobi?
At Sobi, our values guide everything we do: Care, Ambition, Urgency, Ownership, Partnership. If you share these values and want to help shape the future of rare disease treatment, we’d love to hear from you.
All your information will be kept confidential according to EEO guidelines.

Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases.
We are dedicated to capturing the scientific opportunities of our time. With our early roots in Sweden, we started as pioneers in haemophilia. Today we are an innovative leader within rare diseases with a global reach. Together we are bringing brilliant ideas to life.
Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK 26 billion. Sobi’s share (STO:SOBI) is listed on Nasdaq Stockholm. More about Sobi at sobi.com and LinkedIn.